ArticleFrontiers in neurology2026
Combined biofeedback and vestibular rehabilitation therapy for vestibular migraine: clinical efficacy and neurobiochemical correlates.
Article in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Vestibular migraine (VM) is a prevalent cause of recurrent vertigo with limited standardized treatment options. While vestibular rehabilitation and biofeedback therapy have individually demonstrated efficacy, their combined application and effects on neurobiochemical markers remain unexplored. Methods: This prospective comparative study enrolled 148 patients with VM at a single tertiary center between January 2022 and March 2024. Patients were allocated to four groups ( Results: Combined therapy achieved a significantly higher total effective rate (94.59%) compared to biofeedback (78.38%), vestibular rehabilitation (75.68%), and routine intervention (67.57%) ( Conclusion: Combined biofeedback and vestibular rehabilitation therapy provides superior clinical efficacy and favorable neurobiochemical modulation in patients with vestibular migraine, supporting its application as a promising non-pharmacological treatment strategy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.